NYMOX PHARMACEUTICAL CORPORATION Key Management Personnel Compensation Postemployment Benefits
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Key Management Personnel Compensation Postemployment Benefits of $7.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2025-06-03
| Period end | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|
| 2024-12-31 | $7.00K 20-F · filed 2025-06-03 |
| 2023-12-31 | $7.00K 20-F · filed 2025-06-03 |
| 2022-12-31 | $9.00K 20-F · filed 2025-06-03 |
| 2021-12-31 | $70.00K 20-F · filed 2024-08-29 |
| 2020-12-31 | $18.00K 20-F · filed 2023-05-02 |
| 2019-12-31 | $16.00K 20-F · filed 2022-03-30 |
| 2018-12-31 | $49.00K 20-F · filed 2021-03-29 |
| 2017-12-31 | $18.00K 20-F · filed 2020-03-30 |
| 2016-12-31 | $18.00K 20-F · filed 2019-03-29 |
| 2015-12-31 | $16.00K 20-F · filed 2018-03-30 |